We serve Chemical Name:1,1,3,3,5,5-hexamethyl-1,3,5-trisilinane CAS:1627-99-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1,1,3,3,5,5-hexamethyl-1,3,5-trisilinane
CAS.NO:1627-99-2
Synonyms:1,3,5-Trisilacyclohexane,1,1,3,3,5,5-hexamethyl;1.1.3.3.5.5-Hexamethyl-1.3.5-trisilacyclohexan;1,1,3,3,5,5-hexamethyl-[1,3,5]trisilinane;1.1.3.3.5.5-hexamethyl-1.3.5-trisilacyclohexane;1,1,3,3,5,5-Hexamethylcyclotrimethylenetrisilane;1,1,3,3,5,5-Hexamethyl-[1,3,5]trisilinan
Molecular Formula:C9H24Si3
Molecular Weight:216.54300
HS Code:3910000000
Physical and Chemical Properties:
Melting point:N/A
Boiling point:208.3ºC at 760mmHg
Density:0.81g/cm3
Index of Refraction:
PSA:
Exact Mass:216.11900
LogP:3.74280
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1,3,5-Trisilacyclohexane,1,1,3,3,5,5-hexamethyl chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,1,3,3,5,5-Hexamethyl-[1,3,5]trisilinan physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,1,3,3,5,5-Hexamethyl-[1,3,5]trisilinan Use and application,1.1.3.3.5.5-Hexamethyl-1.3.5-trisilacyclohexan technical grade,usp/ep/jp grade.
Related News: Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. lithium,N-[bis[dimethylamino(dimethyl)silyl]methyl-dimethylsilyl]-N-methylmethanamine manufacturers Additionally, Charles River provides paid time-off for its employees to volunteer for charitable and community organisations. 2,2,5,5,8,8,11,11,13,13,16,16-dodecamethyl-2,5,8,11,13,16-hexasilabicyclo[10.4.2]octadeca-1(17),12(18),17-trien-6-yne suppliers The jury unanimously ruled in Plexxikon’s favor on all seven questions, including that Novartis has not proved the specification of the patent was full and clear enough to enable a person of “ordinary skill” to make and use the invention. PARECOXIB NA vendor & factory.
